{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:07:35Z","timestamp":1790352455224,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009455","name":"West Virginia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009455","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009455","name":"West Virginia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009455","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.prro.2018.09.003","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T03:55:22Z","timestamp":1538020522000},"page":"e90-e97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors"],"prefix":"10.1016","volume":"9","author":[{"given":"Sean M.","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Alfredo","family":"Siochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm D.","family":"Mattes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2018.09.003_bib1","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2018.09.003_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lungcan.2009.05.007","article-title":"Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial","volume":"68","author":"Ricardi","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prro.2018.09.003_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2008.11.042","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung carcinoma: 4-year results of a prospective phase II study","volume":"75","author":"Fakiris","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.09.003_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ijrobp.2010.04.056","article-title":"Prospective, risk-adapted strategy of stereotactic body radiation therapy for early-stage non-small cell lung cancer: Results of a phase II trial","volume":"80","author":"Bral","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.09.003_bib5","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1200\/JCO.2008.21.5681","article-title":"Outcome in a prospective phase II trial of medically inoperable stage I non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"27","author":"Baumann","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2015.01.045","article-title":"Stereotactic body radiation therapy for non-small cell lung cancer tumors greater than 5 cm: Safety and efficacy","volume":"92","author":"Woody","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.09.003_bib7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cncr.30375","article-title":"Multi-institutional experience of stereotactic body radiation therapy for large (\u22655 centimeters) non-small cell lung tumors","volume":"123","author":"Verma","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2018.09.003_bib8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cllc.2016.11.020","article-title":"Stereotactic body radiation therapy for large (>5 cm) non-small cell lung cancer","volume":"18","author":"Peterson","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.prro.2018.09.003_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jtcvs.2010.01.046","article-title":"Size matters: A comparison of T1 and T2 peripheral non-small cell lung cancers treated with stereotactic body radiation therapy (SBRT)","volume":"140","author":"Dunlap","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.prro.2018.09.003_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1748-717X-2-21","article-title":"Exceptionally high incidence of symptomatic grade 2 to 5 radiation pneumonitis after stereotactic radiation therapy for lung tumors","volume":"2","author":"Yamashita","year":"2007","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1748-717X-5-32","article-title":"Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiation therapy","volume":"5","author":"Yamashita","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2011.04.002","article-title":"Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions","volume":"99","author":"Stauder","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.radonc.2010.10.003","article-title":"Treatment of large stage I-II lung tumors using stereotactic body radiation therapy (SBRT): Planning considerations and early toxicity","volume":"97","author":"Ong","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib14","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.ijrobp.2012.01.018","article-title":"Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer","volume":"83","author":"Matsuo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.09.003_bib15","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s10147-014-0766-3","article-title":"Timing and characteristics of radiation pneumonitis after stereotactic body radiation therapy for peripherally located stage I lung cancer","volume":"20","author":"Kanemoto","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jrr\/rrt080","article-title":"Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiation therapy for pulmonary metastases","volume":"55","author":"Jo","year":"2014","journal-title":"J Radiat Res"},{"key":"10.1016\/j.prro.2018.09.003_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.radonc.2010.04.027","article-title":"Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiation therapy","volume":"97","author":"Guckenberger","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib18","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/JTO.0b013e318293dc45","article-title":"Safety and efficacy of stereotactic body radiation therapy for stage 1 non-small cell lung cancer in routine clinical practice: A patterns-of-care and outcome analysis","volume":"8","author":"Guckenberger","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.radonc.2009.02.003","article-title":"Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy","volume":"91","author":"Borst","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijrobp.2010.08.056","article-title":"A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"82","author":"Barriger","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.09.003_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijrobp.2012.03.041","article-title":"Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung","volume":"85","author":"Baker","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.09.003_bib22","series-title":"Contouring Atlas","author":"Kong","year":"2017"},{"key":"10.1016\/j.prro.2018.09.003_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2018.09.003_bib24","series-title":"National Cancer Institute Common Toxicity Criteria for Adverse Events v. 4.0","year":"2009"},{"key":"10.1016\/j.prro.2018.09.003_bib25","series-title":"Classification and regression trees","author":"Stone","year":"1984"},{"key":"10.1016\/j.prro.2018.09.003_bib26","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","article-title":"Hypofractionated stereotactic radiation therapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study","volume":"2","author":"Onishi","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib27","first-page":"336","article-title":"Radiation dose effect in locally advanced non-small cell lung cancer","volume":"6","author":"Kong","year":"2014","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.prro.2018.09.003_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijrobp.2008.06.1939","article-title":"Dose-response relationship for image guided stereotactic body radiation therapy of pulmonary tumors: Relevance of 4D dose calculation","volume":"74","author":"Guckenberger","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.09.003_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1748-717X-7-152","article-title":"Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiation therapy for stage I non-small cell lung cancer","volume":"7","author":"Chang","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/02841860802520821","article-title":"Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy","volume":"48","author":"Ricardi","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2013.10.011","article-title":"Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiation therapy delivered using volumetric modulated arcs","volume":"109","author":"Bongers","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2018.09.003_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/0284186X.2010.521192","article-title":"Heart irradiation as a risk factor for radiation pneumonitis","volume":"50","author":"Huang","year":"2011","journal-title":"Acta Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018302662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018302662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:21:44Z","timestamp":1761819704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850018302662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1879850018302662"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2018.09.003","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2018.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}